Phase II trial of gemcitabine and nab‐paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer Foundation - Concepedia

Concepedia

Publication | Open Access

Phase II trial of gemcitabine and nab‐paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer Foundation

DOI Full Paper Access

22

Citations

30

References

2020

Year

Javier Oesterheld, Damon R. Reed, Bhuvana A. Setty, Michael S. Isakoff, Patrick Thompson, Hong Yin, Masanori Hayashi, David M. Loeb, Tiffany Smith, Rikesh Makanji,

Pediatric Blood & Cancer

Abstract

In patients with heavily pretreated Ewing sarcoma, the confirmed response rate of 9% was similar to multi-institutional studies of gemcitabine and docetaxel.

References

	Year	Citations

Page 1